- 2009-06-26 MorphoSys Announces Clinical Milestone in Therapeutic Antibody ProgramSeventh HuCAL Antibody to Enter Clinical Trials
- 2009-06-25 Zila Enters into Merger Agreement with Tolmar
- 2009-06-25 Miraculins Completes Agreements with Diagnostic Technologies Ltd. and CIIRDF
- 2009-06-24 Perrigo Confirms That Its Partner Synthon Has Filed For Generic Version Of Xyzal® Solution And Announcement Of Lawsuit By SEPRACOR/UCB
- 2009-06-24 ImmunoCellular Therapeutics Signs Manufacturing Agreement with Formatech for Clinical Trial of ICT-121 Immunotherapy
- 2009-06-24 Acusphere, Inc. Announces Amended Terms of Cephalon Agreements
- 2009-06-24 Atox Bio and Fast-Track Drugs & Biologics Sign an R&D Collaboration Agreement for the Development of Therapeutics for Sepsis and Septic Shock
- 2009-06-24 Acusphere, Inc. Announces Amended Terms of March 2008 License Agreements wit Cephalon
- 2009-06-24 HanAll Pharmaceutical Co., Ltd. acquires global rights to Nautilus Biotech’s protein engineering technology for developing novel oral and injectable therapeutic proteins
- 2009-06-23 GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs
